These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 27177805)

  • 41. Defining and Predicting Opioid and Cocaine Treatment Response.
    Gardner RA; Epstein DH; Preston KL; Phillips KA
    Subst Use Misuse; 2019; 54(13):2134-2143. PubMed ID: 31315479
    [No Abstract]   [Full Text] [Related]  

  • 42. Heroin-assisted treatment (HAT) a decade later: a brief update on science and politics.
    Fischer B; Oviedo-Joekes E; Blanken P; Haasen C; Rehm J; Schechter MT; Strang J; van den Brink W
    J Urban Health; 2007 Jul; 84(4):552-62. PubMed ID: 17562183
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hydromorphone Compared With Diacetylmorphine for Long-term Opioid Dependence: A Randomized Clinical Trial.
    Oviedo-Joekes E; Guh D; Brissette S; Marchand K; MacDonald S; Lock K; Harrison S; Janmohamed A; Anis AH; Krausz M; Marsh DC; Schechter MT
    JAMA Psychiatry; 2016 May; 73(5):447-55. PubMed ID: 27049826
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 'This is hardcore': a qualitative study exploring service users' experiences of Heroin-Assisted Treatment (HAT) in Middlesbrough, England.
    Riley F; Harris M; Poulter HL; Moore HJ; Ahmed D; Towl G; Walker T
    Harm Reduct J; 2023 May; 20(1):66. PubMed ID: 37173697
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Variants of opioid system genes are associated with non-dependent opioid use and heroin dependence.
    Randesi M; van den Brink W; Levran O; Blanken P; Butelman ER; Yuferov V; da Rosa JC; Ott J; van Ree JM; Kreek MJ
    Drug Alcohol Depend; 2016 Nov; 168():164-169. PubMed ID: 27664554
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Outpatient versus inpatient opioid detoxification: a randomized controlled trial.
    Day E; Strang J
    J Subst Abuse Treat; 2011 Jan; 40(1):56-66. PubMed ID: 21036514
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Self-reported cravings for heroin and cocaine during maintenance treatment with slow-release oral morphine compared with methadone: a randomized, crossover clinical trial.
    Falcato L; Beck T; Reimer J; Verthein U
    J Clin Psychopharmacol; 2015 Apr; 35(2):150-7. PubMed ID: 25679130
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Commentary on Metrebian et al (2015): What is addiction treatment research about? Some comments on the secondary outcomes of the Randomized Injectable Opioid Treatment Trial.
    Uchtenhagen A
    Addiction; 2015 Mar; 110(3):491-3. PubMed ID: 25678293
    [No Abstract]   [Full Text] [Related]  

  • 49. Effectiveness of community treatments for heroin and crack cocaine addiction in England: a prospective, in-treatment cohort study.
    Marsden J; Eastwood B; Bradbury C; Dale-Perera A; Farrell M; Hammond P; Knight J; Randhawa K; Wright C;
    Lancet; 2009 Oct; 374(9697):1262-70. PubMed ID: 19800681
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Heroin-assisted treatment for opioid dependence: randomised controlled trial.
    Haasen C; Verthein U; Degkwitz P; Berger J; Krausz M; Naber D
    Br J Psychiatry; 2007 Jul; 191():55-62. PubMed ID: 17602126
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison between heroin and heroin-cocaine polyabusers: a psychopathological study.
    Bandettini Di Poggio A; Fornai F; Paparelli A; Pacini M; Perugi G; Maremmani I
    Ann N Y Acad Sci; 2006 Aug; 1074():438-45. PubMed ID: 17105942
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The suitability of oral diacetylmorphine in treatment-refractory patients with heroin dependence: A scoping review.
    F Martins ML; Wilthagen EA; Oviedo-Joekes E; Beijnen JH; de Grave N; Uchtenhagen A; Beck T; Van den Brink W; Schinkel AH
    Drug Alcohol Depend; 2021 Oct; 227():108984. PubMed ID: 34482044
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of psychiatric comorbidity on treatment outcome in patients undergoing diamorphine or methadone maintenance treatment.
    Schäfer I; Eiroa-Orosa FJ; Verthein U; Dilg C; Haasen C; Reimer J
    Psychopathology; 2010; 43(2):88-95. PubMed ID: 20068379
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Cost-Effectiveness of Financial Incentives to Achieve Heroin Abstinence in Individuals With Heroin Use Disorder Starting New Treatment Episodes: A Cluster Randomized Trial-Based Economic Evaluation.
    Shearer J; Metrebian N; Weaver T; Goldsmith K; Strang J; Pilling S; Mitcheson L; Day E; Dunn J; Glasper A; Akhtar S; Bajaria J; Charles V; Desai R; Haque F; Little N; McKechnie H; Mosler F; Mutz J; Poovendran D; Byford S
    Value Health; 2023 May; 26(5):658-665. PubMed ID: 36509367
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Physical and mental health in severe opioid-dependent patients within a randomized controlled maintenance treatment trial.
    Reimer J; Verthein U; Karow A; Schäfer I; Naber D; Haasen C
    Addiction; 2011 Sep; 106(9):1647-55. PubMed ID: 21489005
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Contingency management reduces drug-related human immunodeficiency virus risk behaviors in cocaine-abusing methadone patients.
    Hanson T; Alessi SM; Petry NM
    Addiction; 2008 Jul; 103(7):1187-97. PubMed ID: 18494842
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The therapeutic workplace to promote treatment engagement and drug abstinence in out-of-treatment injection drug users: a randomized controlled trial.
    Holtyn AF; Koffarnus MN; DeFulio A; Sigurdsson SO; Strain EC; Schwartz RP; Leoutsakos JM; Silverman K
    Prev Med; 2014 Nov; 68():62-70. PubMed ID: 24607365
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Heroin-assisted treatment of heroin-addicted patients normalizes regulatory T cells but does not restore CD4
    Hansen W; Luppus S; Barthel R; Chang DI; Broemstrup J; Zwarg T; Shibata J; Westendorf AM; Buer J; Scherbaum N
    Addict Biol; 2021 Jul; 26(4):e12998. PubMed ID: 33336491
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cost-effectiveness of injectable opioid treatment v. oral methadone for chronic heroin addiction.
    Byford S; Barrett B; Metrebian N; Groshkova T; Cary M; Charles V; Lintzeris N; Strang J
    Br J Psychiatry; 2013 Nov; 203(5):341-9. PubMed ID: 24029536
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Multimodal drug addiction treatment: a field comparison of methadone and buprenorphine among heroin- and cocaine-dependent patients.
    Vigezzi P; Guglielmino L; Marzorati P; Silenzio R; De Chiara M; Corrado F; Cocchi L; Cozzolino E
    J Subst Abuse Treat; 2006 Jul; 31(1):3-7. PubMed ID: 16814005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.